Fingerprint
Dive into the research topics of 'Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
Mari Imamura, Abraham Getaneh, David Cooper, Moira Cruickshank, Paul Manson, Arif Adnan Shaukat, Miriam Brazzelli, Graham Scotland
Research output: Book/Report › Commissioned Report